Latest Breaking News On - திசையன் நிலை ஆராய்ச்சி மையம் - Page 6 : comparemela.com

Medical Biological Agency plans to finish pre-clinical trials of Covid vaccine in June

Medical Biological Agency plans to finish pre-clinical trials of Covid vaccine in June
tass.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tass.com Daily Mail and Mail on Sunday newspapers.

Stavropol skiy krayVeronika skvortsovaRussian federal medical biological agencyChumakov federal scientific centerGamaleya national research centerProducts of the russian academy sciencesVector state research centerMicrobiology of the russian healthcare ministryRussian healthcare ministryFederal serviceConsumer rights protectionHuman wellbeingBiological productsRussian academyப்ராடக்ட்ஸ் ஆஃப் தி ரஷ்ய கலைக்கழகம் அறிவியல்திசையன் நிலை ஆராய்ச்சி மையம்

Covid-19 causes twice as many complications as flu, Russian health minister says

According to Mikhail Murashko, vaccination will help avoid not only infection but also serious complications Â© Alexander Astafiev/POOL/TASS MOSCOW, April 10. /TASS/. Covid-19 causes twice as many complications as seasonal influenza and other respiratory diseases, so, vaccination will help avoid not only infection but also serious complications, Russian Health Minister Mikhail Murashko said on Saturday. The novel coronavirus infection has practically twice as many complications, neurological, including psychiatric, as seasonal flu and other acute respiratory diseases. Vaccination is what helps avoid so many problems not only in the course of the disease but also its consequences, he said in an interview with the Rossiya-24 television channel.

Stavropol skiy krayMikhail murashkoProducts of the russian academy scienceChumakov federal scientific centerMicrobiology of the russian health ministryRussian healthGamaleya national research centerVector state research centerRussian health minister mikhail murashkoRussian health ministryBiological productsRussian academyப்ராடக்ட்ஸ் ஆஃப் தி ரஷ்ய கலைக்கழகம் அறிவியல்நுண்ணுயிரியல் ஆஃப் தி ரஷ்ய ஆரோக்கியம் அமைச்சகம்ரஷ்ய ஆரோக்கியம்திசையன் நிலை ஆராய்ச்சி மையம்

Putin not yet received second shot of vaccine - Kremlin spokesman

Putin not yet received second shot of vaccine - Kremlin spokesman
tass.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tass.com Daily Mail and Mail on Sunday newspapers.

Stavropol skiy krayDmitry peskovVladimir putinProducts of the russian academy scienceChumakov federal scientific centerMicrobiology of the russian health ministryGamaleya national research centerVector state research centerRussian president vladimir putinRussian health ministryBiological productsRussian academyவிளாடிமிர் புட்டின்ப்ராடக்ட்ஸ் ஆஃப் தி ரஷ்ய கலைக்கழகம் அறிவியல்நுண்ணுயிரியல் ஆஃப் தி ரஷ்ய ஆரோக்கியம் அமைச்சகம்திசையன் நிலை ஆராய்ச்சி மையம்

Russian Health Ministry Authorizes Clinical Trials of EpiVacCorona-N Vaccine

https://sputniknews.com/russia/202104091082578578-russian-health-ministry-authorises-clinical-trials-of-epivaccorona-n-vaccine/ MOSCOW (Sputnik) - The Russian Health Ministry has authorized phase 1 and 2 clinical trials of EpiVacCorona-N, one more coronavirus vaccine developed by the Vector research center, according to the ministry s register. An open study of the safety, tolerability, reactogenicity and immunising power of the EpiVacCorona-N peptide antigen-based vaccine for preventing COVID, involving volunteers aged 18-60 (phase 1-2), the register read. The trials started on April 8 and are set to end on September 30. The EpiVacCorona vaccine, developed by the Vector State Research Centre of Virology and Biotechnology, is a peptide-based drug that relies on a promising synthetic platform. It consists of artificially synthesised short fragments of viral proteins - peptides, through which the immune system learns how to recognise and then neutralise the virus.

Vector state research centre of virologyVector state research centreதிசையன் நிலை ஆராய்ச்சி மையம் ஆஃப் வைராலஜிதிசையன் நிலை ஆராய்ச்சி மையம்

Russian Health Ministry issues permit for trials of EpiVacCorona-N vaccine

Volunteers aged 18 to 60 will participate in the trials MOSCOW, April 9. /TASS/. The Russian Health Ministry has issued a permit to conduct Phase One and Two clinical trials of the EpiVacCorona-N vaccine against the coronavirus developed by the Vector State Research Center, according to the Ministry’s state registry of trial permits. Volunteers aged 18 to 60 will participate in the trials, the entry stated. The beginning [of trials] is April 8, 2021, the completion - September 30, 2021, the notice specified. The trials will involve 300 volunteers and will be conducted at the medical facility of the Federal Medical Biological Agency in the Novosibirsk Region.

Novosibirskaya oblastVector state research centerRussian health ministryPhase oneFederal medical biological agencyதிசையன் நிலை ஆராய்ச்சி மையம்ரஷ்ய ஆரோக்கியம் அமைச்சகம்கட்டம் ஒன்று